Evidence map›Paper›PMID 40703641›Full record

ReviewJournal of inflammation research2025

Mechanosensitive miRNAs in Cartilage and Subchondral Bone Remodeling: Emerging Targets for Osteoarthritis Therapy.

Xiaobin Shang

Abstract readReview
In one paragraph

Review in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Xiaobin ShangDepartment of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is a chronic degenerative joint disorder characterized by cartilage degradation and bone remodeling. Mechanical stimuli play fundamental roles in maintaining joint homeostasis by regulating cellular metabolism and the composition and stiffness of the extracellular matrix (ECM). Consequently, targeting mechanics-associated factors represent a promising therapeutic direction for OA. MicroRNAs (miRNAs), a class of short non-coding RNAs, negatively regulate target mRNAs at the posttranscriptional level and modulate gene expression in recipient cells without altering gene sequences. Growing interest surrounds the impact of mechanical forces on cellular responses and associated epigenetic gene expression. Therefore, investigating miRNA expression under mechanical loading conditions is crucial for elucidating the role of mechanosensitive miRNAs in articular cartilage and bone metabolism. This highlights specific miRNAs as potential therapeutic targets to disrupt the pathological feedback loops in OA. In this review, we examine the current applications of mechanosensitive miRNAs and delivery systems for OA therapy. We further analyze potential factors influencing their application. Significantly, extracellular vesicles (EVs) may facilitate the transport of mechanosensitive miRNAs across the bone-cartilage interface under mechanical stress. This mechanism provides a novel perspective for fully understanding the bidirectional communication between chondrocytes and osteocytes in response to physiological loading, and how its dysregulation contributes to OA pathology. Advancing research on EVs and their miRNA cargo is essential for the effective application of mechanosensitive miRNA-based regulation in intercellular and tissue interactions during OA treatment.

Indexed as

extracellular vesiclesmechanosensitivemicroRNAsosteoarthritis

Identifiers

PMID40703641
PMCPMC12285899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.